- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Tighter rules for Cough syrup marketing companies in West Bengal to prevent health risks

Kolkata: In a move to ensure public safety, the West Bengal Drug Control Directorate has ramped up its surveillance on companies marketing cough syrups across the state.
A directive, cum comprehensive guidelines, was announced on Thursday by a senior government official.
This heightened scrutiny comes after the ban of 'Coldrif' cough syrup in the state, a measure that follows a similar prohibition in Madhya Pradesh following the tragic deaths of multiple children.
The West Bengal government's order is cited as a "precautionary measure" to prevent any loss of life.
As per the rules, no seller can sell or distribute drugs manufactured by any other company in his own name, unless he has a written agreement with the manufacturer. This has been made mandatory under Section 84D in the guidelines. Under Section 84E, the drug marketing company shall be equally responsible for the quality of the product and all kinds of regulatory responsibilities along with the manufacturer.
According to the guidelines, all cough syrup marketing companies in the state, which are getting their products manufactured outside West Bengal, have been asked to submit a copy of the agreement to the licensing authority of the state Drug Control Directorate within the next 15 days.
A copy of the agreement should be sent to the designated email address tellddcwb@gmail.com, which will be reviewed by the directorate.
As per a IANS report, the companies have been instructed to regularly follow the 'Drug Alert' portal, so that they are updated about new information and warnings regarding the safety and quality of the drug.
According to the official, the move will prevent the sale of substandard or unauthorised cough syrups in the market and ensure consumer safety. A few days ago, the Union Health Ministry issued guidelines. The Health Ministry has directed caution in the use of cough and cold medicines, especially for children.
Incidentally, after the deaths of children in Madhya Pradesh and Rajasthan, the administrative level surveillance and strictness of rules have increased across the country regarding cough syrups.
Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers. Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in.